Stay updated on Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:42.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 in the page header; the update does not alter study details or results.
    Difference
    0.1%
    Check dated 2026-03-19T06:00:09.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added page revision label Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:01:25.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    No substantive content changes detected; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-03-04T22:47:22.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed older notices (including the government funding lapse alert and Revision: v3.4.1). These are maintenance-related changes and do not affect the study details.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:53.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    A government funding notice was added to the page and the revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:16:30.000Z thumbnail image

Stay in the know with updates to Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.